The unofficial start to the Q1 earnings season will kick off next week, but there will still be a decent number of earnings announcements this week. These quarterly results could serve as a sign of what is to come over the course of the next month or so. Here are four stocks for traders to keep an eye on heading into earnings.
The agricultural products company Monsanto (NYSE:MON) is slated to announce its fiscal Q2 earnings prior to the market open on Wednesday. The consensus among analysts is that the company will check in with an 8.8% pop in EPS on a 6.6% increase in total revenue when compared to the year-ago quarter. Shares of MON have risen 5.1% so far this year.
In Monsanto’s fiscal Q1, the company swung to a profit of $0.02 per share from its ongoing business operations versus a net loss of $0.02 per share for the same metric in the company’s fiscal Q1 in 2010. This turnaround was powered by a rise in seeds and traits revenue for corn and soybeans. Monsanto has also benefitted from a broad-based increase in demand for its products from emerging markets such as Argentina and Brazil. For more, see here.
After the market close on Wednesday, the medical diagnostic substances company Immucor (NASDAQ:BLUD) will announce its fiscal Q3 results. Wall Street is calling for the company to report a 3.6% decline in EPS and a 1.0% drop-off in total revenue versus the prior year quarter. Shares of BLUD have been virtually flat since the beginning of the year. For more, see here.
Home Sweet Home
Traders will have a chance to bet on the outcome of the fiscal Q4 results of Bed Bath and Beyond (NASDAQ:BBBY) before the company reports on Wednesday evening. The consensus among analysts is that the company will report a 12.8% uptick in EPS on a 6.6% gain in total revenue in comparison to the year-ago quarter. Shares of BBBY are down 0.9% year-to-date.
Last quarter, Bed Bath and Beyond reported that its quarterly comparable sales increased by approximately 7.0%. The strength in the company’s results enabled management to revise its full year forecast upwards to reflect diluted EPS growth of 25.0%. The company’s board of directors also authorized a new $2 billion share repurchase program during Bed Bath and Beyond’s Q3. For more, see here.
One other stock for traders to keep an eye on during the next few trading sessions is Pier 1 Imports (NYSE:PIR). Analysts are expecting the company to report a 46.9% jump in EPS on a 7.5% rise in sales on a year-over-year basis. Pier 1 will release its fiscal Q4 results prior to the opening bell on Thursday. PIR shares have fallen slightly in 2011, but are up 47.1% over the last 52 weeks. For more, see here.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.